Epiq Partners, LLC Aqua Bounty Technologies, Inc. Transaction History

Epiq Partners, LLC

$165 Million
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 18, 2023	SELL	$0.22 - $0.4 $7,370 - $13,400	-33,500 Reduced 1.71%	1,930,062 $463,000
Q2 2023 Jul 12, 2023	BUY	$0.35 - $0.6 $1,785 - $3,060	5,100 Added 0.26%	1,963,562 $706,000
Q1 2023 Apr 12, 2023	BUY	$0.55 - $1.17 $169,207 - $359,950	307,650 Added 18.64%	1,958,462 $1.18 Million
Q4 2022 Jan 06, 2023	SELL	$0.6 - $17.32 $3,510 - $101,322	-5,850 Reduced 0.35%	1,650,812 $0
Q3 2022 Oct 14, 2022	BUY	$0.8 - $15.88 $99,863 - $1.98 Million	124,829 Added 8.15%	1,656,662 $1.29 Million
Q2 2022 Jul 07, 2022	BUY	$1.18 - $2.04 $67,024 - $115,872	56,800 Added 3.85%	1,531,833 $2.62 Million
Q1 2022 Apr 27, 2022	BUY	$1.34 - $2.26 $171,998 - $290,086	128,357 Added 9.53%	1,475,033 $2.76 Million
Q4 2021 Jan 25, 2022	BUY	$2.1 - $4.36 $1.34 Million - $2.78 Million	637,165 Added 89.8%	1,346,676 $2.83 Million
Q3 2021 Oct 19, 2021	SELL	$3.9 - $5.67 $27,300 - $39,690	-7,000 Reduced 0.98%	709,511 $2.89 Million
Q2 2021 Aug 02, 2021	BUY	$4.85 - $6.9 $203,753 - $289,875	42,011 Added 6.23%	716,511 $3.84 Million
Q1 2021 Apr 16, 2021	BUY	$6.09 - $12.2 $120,277 - $240,950	19,750 Added 3.02%	674,500 $4.52 Million
Q4 2020 Jan 11, 2021	SELL	$3.56 - $10.21 $488,040 - $1.4 Million	-137,090 Reduced 17.31%	654,750 $5.74 Million
Q3 2020 Oct 22, 2020	BUY	$2.49 - $5.16 $348,948 - $723,122	140,140 Added 21.5%	791,840 $3.17 Million
Q2 2020 Aug 03, 2020	BUY	$1.65 - $3.4 $30,525 - $62,900	18,500 Added 2.92%	651,700 $2.1 Million
Q1 2020 Apr 20, 2020	BUY	$1.52 - $2.66 $962,464 - $1.68 Million	633,200 New	633,200 $1.03 Million

Others Institutions Holding AQB

# of Institutions

Shares Held

5.32M

Call Options Held

Put Options Held

View Full List

About AquaBounty Technologies, Inc.

Ticker AQB
Exchange NASDAQ
Sector Consumer Defensive
Industry Farm Products
Shares Outstandng 71,110,704
Market Cap $51.2M
Description
AquaBounty Technologies, Inc., a biotechnology company, focuses on enhancing productivity in the commercial aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It offers AquAdvantage Salmon, a bioengineered Atlantic salmon for human consumption; and sel...

More about AQB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Epiq Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Epiq Partners, LLC with notifications on news.

Account